Cylene Pharmaceuticals Inc.
|
|
|
|
|
created a diverse portfolio of small molecule product candidates; including first-in-class kinase inhibitors; as well as innovative Nucleolus Targeting Agents (NTAs); which selectively kill cancer cells | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|